Healio9 天
GOLD COPD exacerbation history groups ‘mediocre’ in exacerbation risk estimation
The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, COPD exacerbation history groups were “mediocre” in ...
Healio2 天
Patients with COPD plus depression or anxiety experience greater disease burden
Patients with COPD plus a depression/anxiety disorder had poorer scores related to disease burden and health-related quality of life, according to data published in Chronic Obstructive Pulmonary ...
News-Medical.Net on MSN3 天
Long-term inhaled corticosteroids linked to increased health risks in COPD patients
Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended ...
Medindia3 天
Inhaled Corticosteroids for Lung Disease: Relief Today, Risk Tomorrow
Long-term inhaled corticosteroid (ICS) use for chronic obstructive pulmonary disease/ COPD (lung disease) may increase the ...
Managed Healthcare Executive8 天
Increased Risk of Severe RSV Illness in Adults With Asthma or COPD
Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...
Medscape11 天
Evidence Growing That GLP-1RAs May Reduce COPD Exacerbations and Risks for Other Lung Diseases
Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...
Pulmonology Advisor9 天
Dupilumab Improves Symptoms, HRQOL in COPD With Type 2 Inflammation
Dupilumab vs placebo was linked to improved health-related quality of life and respiratory symptoms in patients with COPD and T2 inflammation.